Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction.

Immune responses against MDA-modified collagen type IV are associated with more severe carotid disease and increased risk of MI. These immune responses may reflect LDL oxidation in the artery wall, but could also affect the atherosclerotic disease process.